Taksa Lifescience Private Limited
About Taksa Lifescience Private Limited
Data last updated:
Taksa Lifescience Private Limited is a private limited company based in Chandigarh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 09 May 2023.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U21001CH2023PTC045057.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹65 Lakh. It is led by directors Ravinder Kumar Sharma and Gaurav Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 108, Sector 21 – A, Chandigarh, India – 160022.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.32 Cr. For the same year it recorded a net profit of ₹7.85 Lakh (net margin 0.6%) and EBITDA of ₹61.37 Lakh (EBITDA margin 4.6%).
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹3.92 Cr on record. Court records list 13 cases involving the company, including 13 filed against it; 11 cases are pending.
Company details
Contact details
Taksa Lifescience Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressHouse No – 108, Sector 21 – A, Chandigarh, India – 160022
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Taksa Lifescience is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Taksa Lifescience Private Limited, buy the company report.
Financials of Taksa Lifescience Private Limited
FY 2025 filings availableTaksa Lifescience Private Limited reported revenue of ₹13.32 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹61.37 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹7.85 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.6% | |
| Net Profit Margin | 0.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Taksa Lifescience Private Limited, buy the company report.
Board of directors of Taksa Lifescience Private Limited
Taksa Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravinder Kumar Sharma | Director | 09 May 2023 | 3 Years 5 Months | Current |
| Gaurav Sharma | Director | 09 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Taksa Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indulge Ventures Private Limited | ₹13.36 Cr (FY 2025) | -15.0% | Nagpur, Maharashtra, India | |||
| Converge Electronics Trading (India) Private Limited | ₹13.36 Cr (FY 2025) | -4.0% | Bangalore, Karnataka, India | |||
| SCL Commercial India Private Limited | ₹13.35 Cr (FY 2024) | 474.0% | New Delhi, Delhi, India | |||
| Real Line Partition Private Limited | ₹13.34 Cr (FY 2025) | 245.0% | Mumbai, Maharashtra, India | |||
| Starteck Int Appliance Private Limited | ₹13.34 Cr (FY 2024) | Mumbai, Maharashtra, India | ||||
| Taksa Lifescience Private Limitedthis company | ₹13.32 Cr (FY 2025) | ₹7.85 Lakh | 0.6% | Chandigarh, India | ||
| Lovkik Traders Private Limited | ₹13.31 Cr (FY 2025) | 35.0% | Pune, Maharashtra, India | |||
| Nestlabs Automation Private Limited | ₹13.3 Cr (FY 2025) | 27.0% | Noida, Uttar Pradesh, India | |||
| Pick Ur Needs E-Commerce Private Limited | ₹13.28 Cr (FY 2025) | 158.0% | Delhi, India | |||
| Sidhsai Healthcare Private Limited | ₹13.26 Cr (FY 2025) | 111.0% | Belgaum, Karnataka, India | |||
| Global Parasol Re-Insurance Brokers Private Limited | ₹13.23 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Taksa Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Dec 2024 | 101034173 | Canara Bank | ₹1 Cr | Open | |
| 11 Aug 2024 | 100991505 | Hdfc Bank Limited | ₹3.92 Cr | Satisfied |
To see the full charge records of Taksa Lifescience Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Taksa Lifescience Private Limited has 13 court cases on record: 13 filed against it. 11 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 11 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Zoic Biotech Private Limited | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed against the company by Samchem India Private Limited | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Ms Ster Chem | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Century Pharmaceuticals Limited., Authorized Signatory Mr. Balkrishna Shetty | Pending |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Century Pharmaceuticals Limited., Authorized Signatory Mr. Balkrishna Shetty | Disposed |
To see the full case history of Taksa Lifescience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Taksa Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Taksa Lifescience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Taksa Lifescience Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Ayush Sharma ceased to be Director on 01 Apr 2025.
Frequently asked questions
Taksa Lifescience is an active private limited company based in Chandigarh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 09 May 2023 (3+ years old) and is registered under CIN U21001CH2023PTC045057.
Taksa Lifescience has 2 current directors:
- Ravinder Kumar Sharma - Director
- Gaurav Sharma - Director
The latest financial statements of Taksa Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Taksa Lifescience is U21001CH2023PTC045057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taksa Lifescience has 13 court cases on record: 13 filed against it. 11 are pending.
Taksa Lifescience was incorporated on 09 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Taksa Lifescience by revenue are Indulge Ventures Private Limited, Converge Electronics Trading (India) Private Limited, SCL Commercial India Private Limited, Real Line Partition Private Limited, Starteck Int Appliance Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Ayush Sharma ceased to be Director on 01 Apr 2025. Ayush Sharma was appointed as Director on 09 May 2023. Gaurav Sharma was appointed as Director on 09 May 2023. Taksa Lifescience has 4 board changes on record in total.
The registered office of Taksa Lifescience is at House No – 108, Sector 21 – A, Chandigarh, India – 160022.
Taksa Lifescience operates in the pharma industry, in the api manufacturers segment.
Taksa Lifescience has open charges of ₹1 Cr and satisfied charges of ₹3.92 Cr as per latest MCA filings.